Ansa BiotechnologiesNext-generation DNA synthesis using enzymes

Ansa Biotechnologies: Complex DNA Synthesis for Your Most Ambitious Projects

Introduction

Ansa Biotechnologies revolutionizes DNA synthesis with proprietary enzymatic technology, enabling the direct synthesis of complex DNA sequences up to 600 bp. Our solutions empower scientists to push the boundaries of their research without the limitations of legacy technologies.

Key Features

• No-Assembly Direct Synthesis: Synthesize complex DNA sequences up to 600 bp without the need for assembly.
• High GC/AT Content: Efficiently synthesize GC- or AT-rich sequences such as promoters.
• Secondary Structures: Handle sequences with secondary structures found in promoters, UTRs, and terminators.
• Repetitive Sequences: Easily synthesize repetitive sequences like CRISPR arrays.

Use Cases

• Healthcare & Pharmaceuticals: Innovate in drug development and genetic research.
• Biological Research: Advance fundamental research with precise DNA synthesis.
• Food & Agriculture: Enhance agricultural biotechnology and food production.
• Industrial Biotechnology: Drive industrial applications with custom DNA sequences.

Pricing

Contact us for a consultation to discuss your specific project needs and receive a customized pricing plan.

Teams

Ansa Biotechnologies is driven by a team of experts dedicated to advancing DNA synthesis technology. Our team collaborates with scientists across various industries to deliver cutting-edge solutions for complex DNA synthesis challenges.